Anastasia I Sotiropoulou

Suggest Changes
Learn More
Locally advanced breast cancer (LABC) remains a major clinical issue despite progress achieved in recent years. Herein, we present the mature results of a multimodality treatment program tailoring(More)
9031 Background: Children undergoing therapy for ALL are known to have impaired immune function. (ASCO 2005, abstract #8541). METHODS We prospectively evaluated the humoral and cellular immunity in(More)
Whereas copper-catalyzed azide-alkyne cycloaddition (CuAAC) between acetylated β-D-glucosyl azide and alkyl or phenyl acetylenes led to the corresponding 4-substituted 1-glucosyl-1,2,3-triazoles in(More)
BACKGROUND Based on phase II data in advanced breast cancer (BC), the fluorouracil, epirubicin, and vinorelbine (FEN) combination was assessed as perioperative chemotherapy, integrated in a(More)
  • 1